{"id":5255,"date":"2021-12-06T11:50:21","date_gmt":"2021-12-06T10:50:21","guid":{"rendered":"https:\/\/ww2.omceoge.it\/?page_id=5255"},"modified":"2021-12-06T11:55:28","modified_gmt":"2021-12-06T10:55:28","slug":"5255-alisa-prot-n-39753-istruzioni-operative-preliminari-per-la-somministrazione-di-anticorpi-monoclonali-anti-sars-cov-2-a-pazienti-covid-positivi","status":"publish","type":"post","link":"https:\/\/www.omceoge.it\/home9\/item\/5255-alisa-prot-n-39753-istruzioni-operative-preliminari-per-la-somministrazione-di-anticorpi-monoclonali-anti-sars-cov-2-a-pazienti-covid-positivi\/","title":{"rendered":"<img src=\"https:\/\/ww2.omceoge.it\/home9\/wp-content\/uploads\/alisa.png\" class=\"custom-title-icon\" style=\" vertical-align:middle; display:inline-block;\">ALISA -Prot. n. 39753 &#8211; Istruzioni operative preliminari per la somministrazione di anticorpi monoclonali anti-SARS &#8211; COV -2 a pazienti COVID positivi &#8230;."},"content":{"rendered":"<p>Pubblichiamo la Comunicazione di ALISA Prot. n. 39753 relativa a ISTRUZIONI OPERATIVE PRELIMINALI PER LA\u00a0SOMMINISTRAZIONE DI ANTICORPI MONOCLONALI\u00a0ANTI-SARS-CoV-2 A PAZIENTI COVID POSITIVI AD<br \/>ALTO RISCHIO DI PROGRESSIONE A COVID-19 GRAVE\u00a0RICOVERATI IN STRUTTURE RESIDENZIALI<\/p>\n<hr class=\"readMore\">\n<div class=\"allegati_pdf\">\n<div class=\"div_pdf_js\"><a data-post-title=\"&lt;img src=&quot;https:\/\/ww2.omceoge.it\/home9\/wp-content\/uploads\/alisa.png&quot; class=&quot;custom-title-icon&quot; style=&quot; vertical-align:middle; display:inline-block;&quot;&gt;ALISA -Prot. n. 39753 &#8211; Istruzioni operative preliminari per la somministrazione di anticorpi monoclonali anti-SARS &#8211; COV -2 a pazienti COVID positivi &#8230;.\" data-context=\"list\" class=\"a_pdf_file\" href=\"\/home8\/media\/k2\/attachments\/alisa.REGISTRO_UFFICIALE.2021.0039753.pdf\"><span class=\"span_pdf_icon\">PDF<img data-post-title=\"&lt;img src=&quot;https:\/\/ww2.omceoge.it\/home9\/wp-content\/uploads\/alisa.png&quot; class=&quot;custom-title-icon&quot; style=&quot; vertical-align:middle; display:inline-block;&quot;&gt;ALISA -Prot. n. 39753 &#8211; Istruzioni operative preliminari per la somministrazione di anticorpi monoclonali anti-SARS &#8211; COV -2 a pazienti COVID positivi &#8230;.\" data-context=\"list\" decoding=\"async\" class=\"img_pdf_js\" src=\"\/home9\/wp-content\/uploads\/pdf-png.png\"><\/span><span class=\"span_pdf_title\">Comunicazione ALISA<\/span><\/a><button type=\"button\" class=\"btn-pdf-preview-trigger\" data-pdf-url=\"\">????<\/button><span class=\"span_pdf_url\"><\/span><\/div>\n<div class=\"div_pdf_js\"><a data-post-title=\"&lt;img src=&quot;https:\/\/ww2.omceoge.it\/home9\/wp-content\/uploads\/alisa.png&quot; class=&quot;custom-title-icon&quot; style=&quot; vertical-align:middle; display:inline-block;&quot;&gt;ALISA -Prot. n. 39753 &#8211; Istruzioni operative preliminari per la somministrazione di anticorpi monoclonali anti-SARS &#8211; COV -2 a pazienti COVID positivi &#8230;.\" data-context=\"list\" class=\"a_pdf_file\" href=\"\/home8\/media\/k2\/attachments\/ISTRUZIONI_OPERATIVE_PRELIMINALI_PER_LA_SOMMINISTRAZIONE_DI_ANTICORPI_MONOCLONALI.pdf\"><span class=\"span_pdf_icon\">PDF<img data-post-title=\"&lt;img src=&quot;https:\/\/ww2.omceoge.it\/home9\/wp-content\/uploads\/alisa.png&quot; class=&quot;custom-title-icon&quot; style=&quot; vertical-align:middle; display:inline-block;&quot;&gt;ALISA -Prot. n. 39753 &#8211; Istruzioni operative preliminari per la somministrazione di anticorpi monoclonali anti-SARS &#8211; COV -2 a pazienti COVID positivi &#8230;.\" data-context=\"list\" decoding=\"async\" class=\"img_pdf_js\" src=\"\/home9\/wp-content\/uploads\/pdf-png.png\"><\/span><span class=\"span_pdf_title\">Istruzioni operative<\/span><\/a><button type=\"button\" class=\"btn-pdf-preview-trigger\" data-pdf-url=\"\">????<\/button><span class=\"span_pdf_url\"><\/span><\/div>\n<div class=\"div_pdf_js\"><a data-post-title=\"&lt;img src=&quot;https:\/\/ww2.omceoge.it\/home9\/wp-content\/uploads\/alisa.png&quot; class=&quot;custom-title-icon&quot; style=&quot; vertical-align:middle; display:inline-block;&quot;&gt;ALISA -Prot. n. 39753 &#8211; Istruzioni operative preliminari per la somministrazione di anticorpi monoclonali anti-SARS &#8211; COV -2 a pazienti COVID positivi &#8230;.\" data-context=\"list\" class=\"a_pdf_file\" href=\"\/home8\/media\/k2\/attachments\/Scheda_Registro_mAbs_COVID-19_30.11.2021.pdf\"><span class=\"span_pdf_icon\">PDF<img data-post-title=\"&lt;img src=&quot;https:\/\/ww2.omceoge.it\/home9\/wp-content\/uploads\/alisa.png&quot; class=&quot;custom-title-icon&quot; style=&quot; vertical-align:middle; display:inline-block;&quot;&gt;ALISA -Prot. n. 39753 &#8211; Istruzioni operative preliminari per la somministrazione di anticorpi monoclonali anti-SARS &#8211; COV -2 a pazienti COVID positivi &#8230;.\" data-context=\"list\" decoding=\"async\" class=\"img_pdf_js\" src=\"\/home9\/wp-content\/uploads\/pdf-png.png\"><\/span><span class=\"span_pdf_title\">Scheda<\/span><\/a><button type=\"button\" class=\"btn-pdf-preview-trigger\" data-pdf-url=\"\">????<\/button><span class=\"span_pdf_url\"><\/span><\/div>\n<div class=\"div_pdf_js\"><a data-post-title=\"&lt;img src=&quot;https:\/\/ww2.omceoge.it\/home9\/wp-content\/uploads\/alisa.png&quot; class=&quot;custom-title-icon&quot; style=&quot; vertical-align:middle; display:inline-block;&quot;&gt;ALISA -Prot. n. 39753 &#8211; Istruzioni operative preliminari per la somministrazione di anticorpi monoclonali anti-SARS &#8211; COV -2 a pazienti COVID positivi &#8230;.\" data-context=\"list\" class=\"a_pdf_file\" href=\"\/home8\/media\/k2\/attachments\/Scheda_elettronica_AIFA_operatore_sanitario_Marzo2021.docx\"><span class=\"span_pdf_icon\">PDF<img data-post-title=\"&lt;img src=&quot;https:\/\/ww2.omceoge.it\/home9\/wp-content\/uploads\/alisa.png&quot; class=&quot;custom-title-icon&quot; style=&quot; vertical-align:middle; display:inline-block;&quot;&gt;ALISA -Prot. n. 39753 &#8211; Istruzioni operative preliminari per la somministrazione di anticorpi monoclonali anti-SARS &#8211; COV -2 a pazienti COVID positivi &#8230;.\" data-context=\"list\" decoding=\"async\" class=\"img_pdf_js\" src=\"\/home9\/wp-content\/uploads\/pdf-png.png\"><\/span><span class=\"span_pdf_title\">Scheda Elettronica<\/span><\/a><button type=\"button\" class=\"btn-pdf-preview-trigger\" data-pdf-url=\"\">????<\/button><span class=\"span_pdf_url\"><\/span><\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Pubblichiamo la Comunicazione di ALISA Prot. n. 39753 relativa a ISTRUZIONI OPERATIVE PRELIMINALI PER LA\u00a0SOMMINISTRAZIONE DI ANTICORPI MONOCLONALI\u00a0ANTI-SARS-CoV-2 A PAZIENTI COVID POSITIVI AD<br \/>ALTO RISCHIO DI PROGRESSIONE A COVID-19 GRAVE\u00a0RICOVERATI IN STRUTTURE RESIDENZIALI<\/p>\n","protected":false},"author":563,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[36,144],"tags":[],"class_list":["post-5255","post","type-post","status-publish","format-standard","hentry","category-news-dell-ordine","category-news1"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.omceoge.it\/home9\/wp-json\/wp\/v2\/posts\/5255","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.omceoge.it\/home9\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.omceoge.it\/home9\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.omceoge.it\/home9\/wp-json\/wp\/v2\/users\/563"}],"replies":[{"embeddable":true,"href":"https:\/\/www.omceoge.it\/home9\/wp-json\/wp\/v2\/comments?post=5255"}],"version-history":[{"count":0,"href":"https:\/\/www.omceoge.it\/home9\/wp-json\/wp\/v2\/posts\/5255\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.omceoge.it\/home9\/wp-json\/wp\/v2\/media?parent=5255"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.omceoge.it\/home9\/wp-json\/wp\/v2\/categories?post=5255"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.omceoge.it\/home9\/wp-json\/wp\/v2\/tags?post=5255"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}